Accreditation Status

Accreditation Council for Pharmacy Education

Binghamton University School of Pharmacy and Pharmaceutical Sciences'
Doctor of Pharmacy program has been granted Candidate status by the
Accreditation Council for Pharmacy Education, 190 South LaSalle Street, Suite
2850, Chicago, IL 60603, 312/644-3575; FAX 866/228-2631, website www.acpeaccredit.org

An explanation of Candidate status is below.

  • ACPE explanation of Candidate status

    With respect to clarification of the meaning of Candidate status, graduates of a program so designed would, in the opinion of ACPE, have the same rights and privileges of those graduates from an accredited program. The Candidate status denotes a developmental program that is expected to mature in accord with stated plans within a defined time period. It should be underscored, however, that decisions concerning eligibility for licensure by examination or reciprocity reside with the respective state boards of pharmacy in accordance with their state statutes and administrative rules. Should Candidate status be awarded to a program, ACPE would, however, make its position known and make recommendations consistent with that position.

Middle States Commission on Higher Education

On Jan. 3, 2017, the Middle States Commission on Higher Education approved the inclusion of the "Professional Practice Degree (Doctor of Pharmacy - PharmD) within the scope of the institution's accreditation."

SUNY Board of Trustees

On March 11, 2015, the School of Pharmacy and Pharmaceutical Sciences received approval from the SUNY Board of Trustees for its plan to confer the Doctor of Pharmacy degree.

New York State Education Department

On Dec. 13, 2016, the New York State Board of Regents authorized Binghamton University to award the PharmD degree. The NYS Education Department reviewed the program and registered it for professional purposes on Feb. 6, 2017. The program's registration was renewed by the NYS Education Department on June 25, 2018. The renewed registration remains in effect until Sept. 1, 2019.